The ImmunoPrecise Rapid Prime System Reduces the Immunization Stage of Hybridoma Production to 18 Days

The ImmunoPrecise Rapid Prime System Reduces the Immunization Stage of Hybridoma Production to 18 Days

Source: Drug Development Technology - July 18, 2017 Category: Pharmaceuticals Source Type: news